WCN25-3929 RITUXIMAB VERSUS MODIFIED PONTICELLI REGIMEN IN THE MANAGEMENT OF PRIMARY MEMBRANOUS NEPHROPATHY IN A TERTIARY CARE CENTRE

association between treatment and relapse was seen (p0.168).Kaplan-Meier analysis revealed no statistically significant difference between two treatment groups for sustainability of complete response (p0.500).Conclusions: The long-term outcomes of MLN showed a promising treatment response but with a high relapse rate.Patients who received MMF had an advantage over those receiving CYC in maintenance of complete response, though relapse rates were independent of treatment type I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.